OFFICIAL LEGAL TITLE
Block, Report, and Suspend Suspicious Shipments Act
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_HR_501.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2023-01-25.
What are the main provisions?
Key points include:
- Companies and pharmacies must now more thoroughly check drug orders for unusual size, frequency, or patterns.
- For suspicious orders, companies and pharmacies will be required to decline fulfillment and report them to the Drug Enforcement Administration (DEA).
- Clear guidelines will be established on what constitutes a "suspicious order" and how due diligence should be performed.
- The goal is to reduce illegal drug trafficking, including opioids, without hindering access to medications for opioid use disorder.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Harshbarger, Diana [R-TN-1].
What is the latest detailed status?
The latest detailed status is: Placed on the Union Calendar, Calendar No. 46.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.
What is the impact of this bill?
We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.